Position in ADCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,696,827
+$10,537,473 QoQ
Shares Held
3,119,154
+849.7% QoQ
Ownership
2.45%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Derivatives in ADCT
reported options exposure · as of Mar 31, 2026CallValue
$506,250
CallShares
135,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $1,131,904,343 across 44 Drug Manufacturers - Specialty & Generic names. ADCT ranks #16 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,649,955 | $195,041,180 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
3,315,973 | $171,402,644 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
1,247,447 | $164,338,667 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
4,595,535 | $140,071,906 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
153,372 | $90,946,528 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,893,845 | $57,042,611 | |
| 7 | PRGO |
PERRIGO Co plc
|
4,279,731 | $45,964,310 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
592,013 | $45,525,799 |
All Filings in ADCT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $506,250 | 135,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $11,696,827 | 3,119,154 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,159,354 | 328,429 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,806,476 | 701,619 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,028,246 | 383,674 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $232,391 | 164,817 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $818,136 | 411,124 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,244,063 | 712,401 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $316,000 | 100,000 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $2,580,000 | 816,456 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,536,862 | 1,010,437 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,436,864 | 2,672,810 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,377,275 | 2,650,251 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,061,920 | 1,424,149 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,496,724 | 1,793,192 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $13,060,300 | 3,401,120 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,025,619 | 420,253 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $460,821 | 57,965 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $815,413 | 40,367 | Shares | Sole | 2022-02-14 | |
| 2020-12-31 | $950,024 | 29,679 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,047,333 | 31,747 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $696,860 | 14,887 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||